View in EDS

Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.

Saved in:
Bibliographic Details
Title: Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.
Authors: Olszewski AJ; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Chorzalska AD; Signal Transduction Laboratory, Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI., Petersen M; Signal Transduction Laboratory, Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI., Ollila TA; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Zayac A; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Kurt H; Department of Pathology and Laboratory Medicine., Treaba DO; Department of Pathology and Laboratory Medicine., Reagan JL; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Hsu A; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Egan PC; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Butera J; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Niroula R; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Vatkevich J; Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI; and., Robison J; Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI; and., Sahin I; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI., Jacob AP; Adaptive Biotechnologies, Seattle, WA., Mullins CD; Adaptive Biotechnologies, Seattle, WA., Dubielecka PM; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI.; Signal Transduction Laboratory, Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI.
Source: Blood advances [Blood Adv] 2021 Dec 28; Vol. 5 (24), pp. 5525-5535.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2021004512